In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum

被引:30
作者
Bibi, Nazia [2 ,5 ]
Tanoli, Sheraz Ahmad K. [3 ]
Farheen, Sadia [1 ]
Afza, Nighat [1 ]
Siddiqi, Salman [4 ]
Zhang, Ying [5 ]
Kazmi, Shahana U. [2 ]
Malik, Abdul [3 ]
机构
[1] Pharmaceut Res Ctr, PCSIR Karachi Labs Complex, Karachi 75280, Pakistan
[2] Univ Karachi, Immunol & Infect Dis Res Lab, Dept Microbiol, Karachi, Pakistan
[3] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem Sci, Karachi 32, Pakistan
[4] Becton Dickinson Diagnost Syst, Sparks, MD 21152 USA
[5] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
Antituberculosis activities; Mycobecterium tuberculosis; Haloxylon salicornicum; Isoniazid; MYCOBACTERIUM-TUBERCULOSIS; NATURAL-PRODUCTS; RESISTANCE; ANTIFUNGAL; MORTALITY;
D O I
10.1016/j.bmcl.2010.05.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In vitro antituberculosis activities of fractions and pure compounds (1-20) including seven triterpenes, two alkaloids, two cycloheximide derivatives, two coumarins six sterol derivatives and a long chain alcohol, respectively, isolated from Haloxylon salicornicum were determined against Mycobecterium tuberculosis H37Rv. Actively growing cultures were tested by rapid colorimetric method while the stationary phase cultures were tested by drug exposure methods for bactericidal activity. The MIC values were found to be 50 mu g/ml for compounds 15, 19 and 20 where as rest of the compounds invariably showed MIC value of 100 mu g/ml against the logarithmic phase culture. These were compare to Isoniazid as a control drug. The compounds exhibited no activity against the stationary phase culture of M. tuberculosis H37Rv up to 200 mu g/ml. Further studies are required to investigate the in vivo efficacies and activities of the compounds in combination with antimicrobials that are already being used for TB therapy. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4173 / 4176
页数:4
相关论文
共 33 条
[1]  
Ali S.I., 2001, FLORA PAKISTAN, V204, P185
[2]  
[Anonymous], 2008, GLOBAL TUBERCULOSIS
[3]  
AYYAZIAN LF, 1993, TUBERCULOSIS, pCH2
[4]   THE ENVELOPE OF MYCOBACTERIA [J].
BRENNAN, PJ ;
NIKAIDO, H .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :29-63
[5]   New fronts in an old war [J].
Butler, D .
NATURE, 2000, 406 (6797) :670-672
[6]   Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model [J].
Byrne, Sean T. ;
Denkin, Steven M. ;
Gu, Peihua ;
Nuermberger, Eric ;
Zhang, Ying .
JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (08) :1047-1051
[7]  
Chopra RN, 1956, GLOSSARY INDIAN MED, P204
[8]  
Collins CH, 1997, TUBERCULOSIS BACTERI, P98
[9]   Plant products as antimicrobial agents [J].
Cowan, MM .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :564-+
[10]   Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method [J].
De Logu, A ;
Pellerano, ML ;
Sanna, A ;
Pusceddu, MC ;
Uda, P ;
Saddi, B .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (03) :244-250